OL Oncology Letters 1792-1074 1792-1082 D.A. Spandidos 10.3892/ol.2019.10394 OL-0-0-10394 Articles Comparison of single utility port video-assisted thoracoscopic surgery (VATS) and three-port VATS for non-small cell lung cancer YeZhongrui ZhangBo ChenYu LinJiang Department of Thoracic Surgery, Taizhou Hospital of Zhejiang Province, Taizhou, Zhejiang 317000, P.R. China Correspondence to: Dr Zhongrui Ye, Department of Thoracic Surgery, Taizhou Hospital of Zhejiang Province, 150 Ximen Street, Linhai, Taizhou, Zhejiang 317000, P.R. China, E-mail: ruq3ae@163.com; tzyezr@163.com 08 2019 22 05 2019 18 2 1311 1317 20112018 24042019 Copyright: © Ye et al. 2019 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Clinical efficacy of single utility port video-assisted thoracoscopic surgery (VATS) and three-port VATS for patients with non-small cell lung cancer (NSCLC) was compared. A total of 156 patients with NSCLC who underwent VATS in Taizhou Hospital of Zhejiang Province from July 2015 to January 2017 were selected as subjects. They were randomly divided into group A (n=74) and group B (n=82), in which group A was treated with single utility port VATS and group B was treated with three-port VATS. Perioperative indicators such as operation time, intraoperative blood loss, postoperative drainage, removal of drainage tube, lymph node dissection, hospitalization time, postoperative complications, postoperative pain and postoperative quality of life were observed. Expression levels of CRP and IL-6 in serum were detected by enzyme-linked immunosorbent assay (ELISA). There was no significant difference in the operation time, postoperative drainage volume, drainage tube removal time and lymph node dissection between groups A and B (P>0.05). Blood loss and hospitalization time in group A were significantly lower than those in group B (P<0.001). VAS scores at 1–3 days after operation in group A were significantly lower than those in group B (P<0.001). Levels of serum CRP and IL-6 at 1–7 days after operation in group A were significantly lower than those in group B (P<0.001). Incidence of complication in group A was not significantly different from that in group B (P>0.05). Overall quality of life scores of group A and B were significantly lower than the preoperative scores (P<0.001). Overall status score of group A was significantly higher than that of group B (P<0.001). Clinical efficacies of single utility port VATS and three-port VATS were similar. Single utility port VATS can reduce trauma during surgery, reduce stress response, relieve postoperative pain, and facilitate the recovery of postoperative quality of life.

 non-small cell lung cancer single utility port video-assisted thoracoscopic surgery three-port video-assisted thoracoscopic surgery clinical efficacy Introduction

Lung cancer is one of the most common malignant tumors and is the leading cause of cancer-related deaths. In 2012, lung cancer accounts for approximately 12.9% of all cancers (1). The most common type of lung cancer is non-small cell lung cancer (NSCLC). NSCLC accounts for 85–90% of lung cancer. NSCLC is mainly divided into adenocarcinoma and squamous cell carcinoma subtypes, which are derived from bronchial mucosa epithelium (2). At present, surgical treatment is the most effective and important method for early NSCLC (3). Although the use of minimally invasive surgery in clinical practice has increased in recent years, thoracotomy is still the most common method of lobectomy (4). Studies have shown that video-assisted thoracoscopic surgery (VATS) brings more benefits to patients with early NSCLC compared with conventional thoracotomy, including reduced hospital stay, relief of recent postoperative pain, and less postoperative complications (5). VATS lobectomy consists of several incisions or ports, usually 3–4. With the development of laparoscopic instrument technology, VATS is gradually reduced from multiple incisions to double incision, namely single utility port thoracoscopic surgery (6). Since 2010, single utility port VATS lobectomy has become a new area of minimally invasive surgery (7). Single utility port VATS is a less invasive surgical procedure. With single utility port VATS, thoracic surgery can be performed through a small incision of approximately 4 cm in diameter. This technique has been increasingly accepted because of its remarkable clinical effect (8). Compared with conventional VATS, single utility port VATS not only have the advantage of reducing surgical trauma, but also reduces postoperative pain and prompts recovery (9). Clinical efficacy of single utility port VATS has been extensively studied, but studies on the post-operative stress response and the impact on quality of life (physical, functional and social) in 3 months after surgery are rare. In this study, single utility port VATS and three-port VATS were performed in patients with NSCLC to compare the clinical efficacy. Postoperative stress response and quality of life were also compared.

 Patients and methods <sec> <title>General information

One hundred and fifty-six patients with NSCLC who underwent VATS in Taizhou Hospital of Zhejiang Province (Taizhou, China) from July 2015 to January 2017 were selected as subjects. Patients were randomly divided into group A (n=74) and group B (n=82). Group A was treated with single utility port VATS and group B was treated with three-port VATS. There were 43 males and 31 females in group A, aged 45–73 years, with a mean age of 62.67±9.16 years; tumor diameter was 1.4–4.8 cm, with mean diameter of 2.81±1.16 cm; TNM staging: 59 cases in stage I, 15 cases in stage II; pathological types: 59 cases of adenocarcinoma, 10 cases of squamous cell carcinoma, 5 cases of adenosquamous carcinoma. There were 59 males and 23 females in group B, aged 41–72 years, with a mean age of 61.83±8.26 years; tumor diameter was 1.3–4.5 cm, with a mean diameter of 2.86±1.35 cm; TNM staging: 64 cases in stage I, 18 cases in stage II; pathological types: 61 cases of adenocarcinoma, 14 cases of squamous cell carcinoma, 7 cases of adenosquamous carcinoma.

 Inclusion and exclusion criteria

Inclusion criteria: Preoperative pathological examination confirmed NSCLC (10); No distant metastases under examination of CT, color Doppler ultrasound, MRI and other imaging examinations, TNM stage was stage I–II; no previous history of chemotherapy and radiation therapy; first diagnosis; aged 18–75 years; Eastern Cancer Cooperative Group (ECOG) (11) physical status was 0–1, expected survival time ≥12 months; no major organ dysfunction.

Exclusion criteria: History of previous thoracoscopic surgery; extensive pleural adhesions; difficulty in maintaining single-lung ventilation during surgery; combined with other tumors, severe liver and kidney dysfunction, connective tissue disease, endocrine and metabolic diseases, hematopoietic dysfunction, infectious diseases; mental illness or family history of mental illness.

This study was approved by The Ethics Committee of Taizhou Hospital of Zhejiang Province. Patients who participated in this research had complete clinical data. The signed informed consents were obtained from the patients or the guardians.

 Treatment

Compound anesthesia was performed. After intubation of the double lumen tube, single lung ventilation was performed into the pleural cavity. Lateral position (90°) on the healthy side was used. After disinfection, observation hole was made in the 7th intercostal space of the midline of the iliac crest. A 2 cm incision was made and thoracoscope was placed. For single utility port VATS, an incision (4 cm) was made between the 4th and 5th ribs of the iliac crest. For three-port VATS, 2 cm incision (main operation hole) was made in the fifth intercostal space of the iliac crest, and another 2 cm incision (sub-operation hole) was made in the 7th intercostal space of the anterior subscapular line. Mediastinal pleura was opened, and the lower ligament of the lower lung was dissected. According to the condition of the resected lung lobe, the venous, arterial, and bronchial organs were dissected by a single-type lobectomy method. The (articular head) intra-cavity linear cutting and closing device was used to close the detachment. Lobes were removed, and mediastinal lymph nodes were also removed. After that, the chest cavity was flushed, the blood was stopped, the drainage tube was placed, and the chest was closed layer by layer.

 Observation indicators

i) Perioperative indicators such as operation time, intraoperative blood loss, postoperative drainage, removal of drainage tube, lymph node dissection, hospitalization time and postoperative complications were observed.

ii) The degree of pain was assessed by visual analog scale (VAS) (12) from 1 to 7 days postoperatively (T1-T7). VAS score of 0 indicated no pain, and VAS score of 10 indicated the most severe pain. The higher the VAS score, the more severe the pain.

iii) Venous blood was taken from the study subjects before and 1–7 days after surgery (T1-T7) under fasting conditions. Blood was centrifuged at 670.8 × g at 20–25°C for 10 min to separate serum. Expression of CRP and IL-6 in serum was detected by enzyme-linked immunosorbent assay (ELISA) (13). Human CRP and IL-6 ELISA kits (Thermo Fisher Scientific Co., Ltd., Shanghai, China) were used. All operations were performed in strict accordance with manufacturer's instructions. No reagent was added into the blank control well. After adding samples, the plate was covered with film and incubated at 37°C for 1 h. After that, the plate was washed and 80 µl affinity chain enzyme was added into each well, followed by incubation at 37°C for 30 min. After that, substrate A and B (50 µl) was added, followed by incubation at 37°C for 10 min. Then each well was added with 50 µl stop solution. OD value of each well was measured at 450 nm by using a fully automated enzyme label analyzer (Miguel Molecular Instruments Co., Ltd., Shanghai, China), and the expression levels of CRP and IL-6 were calculated.

iv) Functional assessment of cancer treatment - The lung cancer questionnaire (FACT-L) (14) was used to assess the quality of life of patients before and 3 months after surgery. FACT-L contains 27 items, including body, function, situation and social fields. Each item has a 5-level scale (0–4 points, 0 = no, 4 = very much).

 Statistical analysis

Statistical analysis was performed using SPSS 19.0 (IBM Corp, Armonk, NY, USA). Measurement data were expressed as mean ± standard deviation, and the inter-group comparisons of measurement data in accordance with the normal distribution were compared by t-test. Comparison with a group before and after treatment was performed by paired t-test. Count data were expressed as number of cases/percentage [n (%)]. Chi-square test was used to compare count data between groups. ANOVA was used for comparison between multiple groups and the post hoc test was LSD test. P<0.05 was considered to indicate a statistically significant difference.

 Results <sec> <title>Baseline data of groups A and B

Groups A and B showed no significant difference in sex, age, body mass index (BMI), smoking and drinking history, lesion location, tumor diameter, TNM stage, pathological type, pathological differentiation, alanine aminotransferase (ALT), aspartate aminotransferase (AST) and blood sugar (Glu) (P<0.05) (Table I).

 Comparison of perioperative indicators between groups A and B

There was no significant difference between the groups in operation time, postoperative drainage volume, drainage tube removal time and lymph node dissection (P>0.05). The blood loss and hospitalization time in group A were significantly lower than those in group B (P<0.001) (Table II).

 Comparison of VAS scores at 1 and 7 days after operation between groups A and B

VAS scores of group A were ssignificantly lower than those of group B at 1–3 days after operation (P<0.001). There was no significant difference between groups A and B at 4–7 days after operation (P>0.05) (Table III and Fig. 1).

 Comparison of serum CRP and IL-6 expression levels between groups A and B before and 1 to 7 days after operation

There was no significant difference in serum CRP and IL-6 expression levels between groups A and B before operation (P>0.05). Levels of serum CRP and IL-6 in group A were significantly lower than those in group B at 1–7 days after operation (P<0.001) (Tables IV and V; Fig. 2).

 Comparison of postoperative complications between groups A and B

In group A, 1 case (1.35%) had lung leak, 2 cases (2.70%) had atelectasis, 6 cases (8.11%) had arrhythmia, and the complication rate was 12.16%. In group B, 2 cases (2.44%) had pulmonary infection, 1 case (1.22%) had lung leak, 3 cases (3.66%) had atelectasis, 8 cases (9.76%) had arrhythmia, and the complication rate was 17.07%. There was no significant difference in the incidence of complications between groups A and B (P>0.05) (Table VI).

 Comparison of quality of life between groups A and B before and after operation

There was no significant difference in physical, functional, emotional, social and additional status scores between groups A and B before and after operation (P>0.05). The overall status score of groups A and B after operation was significantly lower than that before operation (P<0.001), and the overall status score of group A after operation was significantly higher than that of group B (P<0.001) (Table VII).

 Discussion

The number of lung cancer patients has increased in recent years and lung cancer has become the leading cause of human death. For the early treatment of lung cancer, surgical resection is still the main method. Traditional thoracotomy causes severe incision and trauma, and postoperative pain is serious, which makes the quality of life of lung cancer patients greatly reduced (15). With the continuous development of endoscopic techniques, minimally invasive treatment has become a hot research topic that could reduce postoperative complications and improve the quality of life of patients with NSCLC (16). Single utility port VATS is operated with only one incision. With single utility port VATS, thoracoscope and instruments are operated in one hole during the operation, and the trauma is small, and blood vessels and intercostal nerve damage are avoided, and postoperative pain is also lighter (17). Thus, single utility port VATS therapy is receiving increasing attention in clinical treatment of NSCLC.

Previous studies have shown that the surgical incision of single utility port VATS is mostly between 4.0 and 7.0 cm (18). The length of the incision in this study is about 4.0 to 5.0 cm, which is similar to previous studies. Three-port VATS usually requires three incisions. The first incision is generally used as an observation hole between the 7th and 8th intercostals, and second incision is used as the main operation hole in the 5th or 6th intercostal space of the ankle line, and the 3rd incision is a sub-operation hole (19) made between the rear line and the shoulder line.

Single utility port VATS is a modified 2-incision technique in which the operating hole is located at the 4th intercostal space of the incision, and the incision is large enough for the operator to accurately position the endoscopic stapler on the fragile pulmonary vessel; and with less incision on the chest wall, the intercostal nerve injury and intercostal traction could be minimized during surgery (18). Results of this study showed that blood loss in group A was significantly lower than that in group B. The VAS score was significantly lower in group A than that in group B at 1–3 days after operation, suggesting that single utility port VATS performed for patients with NSCLC can reduce intraoperative blood loss, reduce trauma during surgery and reduce postoperative pain, this result is similar with the study of Zhu et al (20). Single utility hole VATS is a single-hole operation and ribs are not pulled, so thoracic damage and pain are relatively light. This may be because single utility port VATS is without rib traction, which causes less pain to the patient's thorax, while 3 holes from the posterior tibial incision as a secondary operation hole. There are many layers of muscles in the thoracic back, abundant blood supply and nerve distribution, narrow rib space, and thus easy to bleed during the incision. An important indicator of successful operation in radical surgery for lung cancer is the hilar mediastinal lymphadenectomy. Effective removal of the hilar and mediastinal lymph nodes during surgery can not only provide reference for postoperative pathological staging, but also affect the prognosis of patients (21,22). The results of Chang et al (23) showed that the total number of single utility port or double-port VATS lymph node dissection was similar. Results of this study showed that there was no significant difference in the number of lymph node dissections between groups A and B. Therefore, single utility port VATS can also achieve the purpose of treating NSCLC.

IL-6 is an acute phase mediator involved in B cell stimulation. Peak value of IL-6 is usually reached 2 h after surgery, and then rapidly decreases in patients without complications. CRP is one of the representatives of acute phase proteins and provides a reliable screening test for acute phase reactants. CRP level reaches peaks between 24 and 72 h after surgery, and its level may continue to rise for approximately 2 weeks (24,25). Therefore, IL-6 and CRP can be used as objective biochemical markers reflecting surgical tissue trauma. Results of this study showed that levels of serum CRP and IL-6 in group A were significantly lower than those in group B at 1 to 7 days after surgery, indicating that single utility port VATS can reduce the surgical trauma and reduce stress response in patients with NSCLC. In addition, results of this study showed that incidence of complication in group A was not significantly different from that in group B, but the length of hospital stay was significantly shorter than that in group B, indicating that single utility port VATS can shorten hospital stay. Dai et al (26) showed that single-pore VATS have the advantages of reducing blood loss and reducing postoperative pain compared with dual-pore VATS. Surgery-induced intercostal nerve injury is an important cause of pain in patients (27). Overall incision length of single utility port VATS is significantly reduced compared with three-port VATS, and intercostal nerve damage is reduced, and the amount of intraoperative blood loss is also reduced. Therefore, complications such as lung infections are inhibited, and hospital stay is shortened.

Quality of life of cancer patients has become an important criterion for the evaluation of tumor treatment efficacy (28). Our 3-month follow-up study showed that there was no significant difference in physical, functional, emotional, social, and additional status scores between the preoperative and postoperative levels in groups A and B. Overall status of group A and B was significantly worse than that of preoperative conditions. Overall status of group A was significantly higher than that of group B, suggesting that VATS will affect the quality of life of patients with NSCLC, but the effect of single utility port VATS on short-term quality of life is better than that of three-port VATS, possibly due to the smaller trauma caused by single utility port VATS. Möller et al (29) followed up patients undergoing lung cancer surgery and found that the SF-36 quality of life score decreased 6 months after surgery, which confirmed that thoracic surgery would affect the quality of life of patients, however, the report also showed Age, extent of resection, and subsequent adjuvant therapy were closely associated with a decline in quality of life associated with physical condition at 6 months postoperatively. Although the differences between the single utility port and three-port VATS perioperative indexes were observed in this study, long-term follow-up results are lacking. The recurrence of cancer was not investigated. Thus, studies with longer follow-up are still required.

In conclusion, clinical efficacies of single utility port VATS and three-port VATS were similar. Single utility port VATS can reduce trauma during surgery, reduce stress response, relieve postoperative pain, and facilitate the recovery of postoperative quality of life.

 Acknowledgements

Not applicable.

 Funding

This study was supported by Taizhou Science and Technology Bureau (no. 14sf03).

 Availability of data and materials

The datasets used and/or analyzed during the present study are available from the corresponding author on reasonable request.

 Authors' contributions

ZY and BZ conceived and designed the study. YC collected the patient data. ZY and JL analyzed and interpreted the patient data regarding the non-small cell lung cancer. ZY and BZ performed the experiment of single utility port VATS and three-port VATS. ZY was a major contributor in writing the manuscript. All authors read and approved the final manuscript.

 Ethics approval and consent to participate

This study was approved by The Ethics Committee of Taizhou Hospital of Zhejiang Province (Taizhou, China). Patients who participated in this research had complete clinical data. The signed informed consents were obtained from the patients or the guardians.

 Patient consent for publication

Not applicable.

 Competing interests

The authors declare that they have no competing interests.

 References ChenWZhengRZengHZhangSEpidemiology of lung cancer in ChinaThorac Cancer6209215201510.1111/1759-7714.1216926273360 BhaumikSAhmadFDasBRMolecular binary classification of NSCLC: miR-375 is a potential biomarker to differentiate SQCC from ADCC in Indian NSCLC patientsAppl Cancer Res3728201710.1186/s41241-017-0034-8 HiguchiMYaginumaHYonechiAKannoROhishiASuzukiHGotohMLong-term outcomes after video-assisted thoracic surgery (VATS) lobectomy versus lobectomy via open thoracotomy for clinical stage IA non-small cell lung cancerJ Cardiothorac Surg988201410.1186/1749-8090-9-8824886655 PaulSSedrakyanAChiuYLNasarAPortJLLeePCStilesBMAltorkiNKOutcomes after lobectomy using thoracoscopy vs thoracotomy: A comparative effectiveness analysis utilizing the Nationwide Inpatient Sample databaseEur J Cardiothorac Surg43813817201310.1093/ejcts/ezs42822826474 YangHXWooKMSimaCSBainsMSAdusumilliPSHuangJFinleyDJRizkNPRuschVWJonesDRLong-term survival based on the surgical approach to lobectomy for clinical stage I nonsmall cell lung cancer: Comparison of robotic, video-assisted thoracic surgery, and thoracotomy lobectomyAnn Surg265431437201710.1097/SLA.000000000000170828059973 NgCSHGonzalez-RivasDD'AmicoTARoccoGUniportal VATS - a new era in lung cancer surgeryJ Thorac Dis714891491201526380777 Gonzalez-RivasDde la TorreMFernandezRMosqueraVXSingle-port video-assisted thoracoscopic left upper lobectomyInteract Cardiovasc Thorac Surg13539541201110.1510/icvts.2011.27474621828107 AnileMDisoDDe GiacomoTRendinaEAVenutaFUniportal thoracoscopic lobectomyAnn Thorac Surg96745201310.1016/j.athoracsur.2013.03.07623910138 AbouarabAARahoumaMKamelMGhalyGMohamedASingle versus multi-incisional video-assisted thoracic surgery: A systematic review and meta-analysisJ Laparoendosc Adv Surg Tech A28174185201810.1089/lap.2017.044629106318 ReckMPopatSReinmuthNDe RuysscherDKerrKMPetersSESMO Guidelines Working GroupMetastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol25(Suppl 3)iii27iii39201410.1093/annonc/mdu19925115305 HannaNHDahlbergSEKolesarJMAggarwalCHirschFRRamalingamSSSchillerJHThree-arm, randomized, phase 2 study of carboplatin and paclitaxel in combination with cetuximab, cixutumumab, or both for advanced non-small cell lung cancer (NSCLC) patients who will not receive bevacizumab-based therapy: An Eastern Cooperative Oncology Group (ECOG) study (E4508)Cancer12122532261201510.1002/cncr.2930825740387 SatoJOhtoriSOritaSYamauchiKEguchiYOchiaiNKuniyoshiKAokiYNakamuraJMiyagiMRadiographic evaluation of indirect decompression of mini-open anterior retroperitoneal lumbar interbody fusion: Oblique lateral interbody fusion for degenerated lumbar spondylolisthesisEur Spine J26671678201710.1007/s00586-015-4170-026245906 SapanHBPaturusiIJusufIPatellongiIMassiMNPusponegoroADAriefSKLabedaIIslamAARendyLPattern of cytokine (IL-6 and IL-10) level as inflammation and anti-inflammation mediator of multiple organ dysfunction syndrome (MODS) in polytraumaInt J Burns Trauma63743201627335696 FerrellBSunVHurriaACristeaMRazDJKimJYReckampKWilliamsACBornemanTUmanGInterdisciplinary palliative care for patients with lung cancerJ Pain Symptom Manag50758767201510.1016/j.jpainsymman.2015.07.005 BendixenMJørgensenODKronborgCAndersenCLichtPBPostoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: A randomised controlled trialLancet Oncol17836844201610.1016/S1470-2045(16)00173-X27160473 HaoZCaiYFuSZhangNFuXComparison study of post-operative pain and short-term quality of life between uniportal and three portal video-assisted thoracic surgery for radical lung cancer resectionZhongguo Fei Ai Za Zhi191221282016(In Chinese)27009816 HiraiKTakeuchiSUsudaJSingle-incision thoracoscopic surgery and conventional video-assisted thoracoscopic surgery: a retrospective comparative study of perioperative clinical outcomesEur J Cardiothorac Surg49(Suppl 1)i37i41201626417062 WangBYLiuCYHsuPKShihCSLiuCCSingle-incision versus multiple-incision thoracoscopic lobectomy and segmentectomy: A propensity-matched analysisAnn Surg261793799201510.1097/SLA.000000000000071224836148 ShenYWangHFengMXiYTanLWangQSingle-versus multiple-port thoracoscopic lobectomy for lung cancer: a propensity-matched studyEur J Cardiothorac Surg49(Suppl 1)i48i53201626464451 ZhuYLiangMWuWZhengJZhengWGuoZZhengBXuGChenCPreliminary results of single-port versus triple-port complete thoracoscopic lobectomy for non-small cell lung cancerAnn Transl Med392201526015934 WangWYinWShaoWJiangGWangQLiuLLiuDWangZZhuZChenHComparative study of systematic thoracoscopic lymphadenectomy and conventional thoracotomy in resectable non-small cell lung cancerJ Thorac Dis64551201424455175 FinleyRMayoJDonaghCLeoJGrantKLamSEnglishJP1. 16–34 The impact of pathology, staging and operative resection on survival and CT evidence of recurrence of early NSCLCJ Thorac Oncol13S640S641201810.1016/j.jtho.2018.08.1003 ChangJMKamKHYenYTHuangWLChenWTsengYLWuMHLaiWWGonzalez-RivasDFrom biportal to uniportal video-assisted thoracoscopic anatomical lung resection: A single-institute experienceMedicine (Baltimore)95e5097201610.1097/MD.000000000000509727749589 LeungKLLaiPBSHoRLKMengWCYiuRYLeeJFLauWYSystemic cytokine response after laparoscopic-assisted resection of rectosigmoid carcinoma: A prospective randomized trialAnn Surg231506511200010.1097/00000658-200004000-0000810749610 FretlandAASokolovAPostriganovaNKazaryanAMPischkeSENilssonPHRognesINBjornbethBAFagerlandMWMollnesTEInflammatory response after laparoscopic versus open resection of colorectal liver metastases: Data from the Oslo-CoMet TrialMedicine (Baltimore)94e1786201510.1097/MD.000000000000178626496309 DaiFMengSMeiLGuanCMaZSingle-port video-assisted thoracic surgery in the treatment of non-small cell lung cancer: A propensity-matched comparative analysisJ Thorac Dis828722878201610.21037/jtd.2016.10.2727867563 MierJMChavarinAIzquierdo-VidalCFiblaJJMolinsLA prospective study comparing three-port video-assisted thoracoscopy with the single-incision laparoscopic surgery (SILS) port and instruments for the video thoracoscopic approach: A pilot studySurg Endosc2725572560201310.1007/s00464-012-2782-623443479 QuintenCMartinelliFCoensCSprangersMARingashJGotayCBjordalKGreimelEReeveBBMaringwaJPatient Reported Outcomes and Behavioral Evidence (PROBE) the European Organization for Research and Treatment of Cancer (EORTC) Clinical GroupsA global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sitesCancer120302311201410.1002/cncr.2838224127333 MöllerASartipyUPredictors of postoperative quality of life after surgery for lung cancerJ Thorac Oncol7406411201210.1097/JTO.0b013e3182398e8222089118

Comparison of VAS scores at 1 and 7 days after operation between groups A and B. *P<0.001.

Comparison of serum (A) CRP and (B) IL-6 expression levels between groups A and B before and 1 to 7 days after operation. *P<0.001.

Baseline data of groups A and B [n (%)]/(mean ± SD).

Items Group A (n=74) Group B (n=82) t/χ2 value P-value
Sex 3.293 0.070
  Male 43 (58.11) 59 (71.95)
  Female 31 (41.89) 23 (28.05)
Age 62.67±9.16 61.83±8.26 0.602 0.548
BMI (kg/m2) 20.47±3.18 20.04±3.07 0.859 0.392
History of smoking 2.212 0.137
  Yes 30 (40.54) 43 (52.44)
  No 44 (59.46) 39 (47.56)
Drinking history 0.562 0.454
  Yes 22 (29.73) 29 (35.37)
  No 52 (70.27) 53 (64.63)
Lesion 0.054 0.816
  Upper left lobe 16 (21.62) 20 (24.39)
  Left lower lobe   8 (10.81) 9 (10.98)
  Right upper lobe 17 (22.97) 17 (20.73)
  Right middle lobe 10 (13.51) 10 (12.20)
  Right lower lobe 23 (31.08) 26 (31.71)
Tumor diameter (cm) 2.81±1.16 2.86±1.35 0.247 0.805
TNM staging 0.066 0.797
  Phase I 59 (79.73) 64 (78.05)
  Phase II 15 (20.27) 18 (21.95)
Pathological type 0.537 0.464
  Adenocarcinoma 59 (79.73) 61 (74.39)
  Squamous cell carcinoma 10 (13.51) 14 (17.07)
  Adenosquamous carcinoma 5 (6.76) 7 (8.54)
Degree of pathological differentiation 0.105 0.746
  Highly differentiated 17 (22.97) 22 (26.83)
  Medium differentiation 47 (63.51) 43 (52.44)
  Low differentiation 10 (13.51) 17 (20.73)
ALT (U/l) 27.47±5.18 26.91±6.33 0.600 0.549
AST (U/l) 17.18±4.27 17.69±4.82 0.696 0.487
Glu (mmol/l   5.97±0.38 6.06±0.47 1.306 0.193

ALT, alanine aminotransferase; AST, aspartate aminotransferase; SD, standard deviation.

Comparison of perioperative indicators between groups A and B (mean ± SD).

Items Group A (n=74) Group B (n=82) t value P-value
Operation time (min) 142.63±52.73 153.66±51.84 1.316 0.190
Intraoperative blood loss (ml) 136.47±42.71 173.41±49.27 4.978 <0.001
Postoperative drainage (ml) 681.21±44.85 692.54±38.41 1.699 0.091
Drainage tube removal time (days)   4.28±0.93   4.51±1.12 1.387 0.168
Number of lymph node dissections (a) 14.17±4.18 13.87±4.41 0.435 0.664
Hospital stay (days)   9.31±1.82 11.34±1.32 8.029 <0.001

SD, standard deviation.

Comparison of VAS scores at 1 and 7 days after operation between groups A and B (mean ± SD).

Time points Group A (n=74) Group B (n=82) t value P-value
T1 5.29±1.34 6.28±1.73 3.685 <0.001
T2 4.19±1.47 5.22±1.58 4.170 <0.001
T3 3.13±1.21 4.56±1.31 6.303 <0.001
T4 2.81±1.38 2.87±1.44 0.374 0.708
T5 2.64±1.63 2.68±1.13 0.689 0.492
T6 2.35±1.27 2.39±1.08 0.546 0.604
T7 2.27±0.46 2.31±0.53 0.938 0.350

Comparison of serum CRP expression levels between groups A and B before and 1–7 days after surgery (mean ± SD, mg/l).

Time points Group A (n=74) Group B (n=82) t value P-value
Before operation 3.15±1.13 3.29±1.27 0.724 0.470
T1 18.64±3.27 24.52±2.41 12.870 <0.001
T2 14.05±2.29 17.49±3.36   7.392 <0.001
T3 10.59±1.15 13.25±2.18   9.382 <0.001
T4   8.25±1.32 11.23±2.57   8.963 <0.001
T5   7.67±1.59   9.67±2.03   6.799 <0.001
T6   5.27±1.24   7.22±1.94   7.390 <0.001
T7   4.38±1.76   6.37±1.89   6.784 <0.001

Comparison of serum IL-6 expression levels between groups A and B before and 1 to 7 days after surgery (mean ± SD, pg/l).

Time points Group A (n=74) Group B (n=82) t value P-value
Before operation 21.53±3.18 22.37±4.18 1.401 0.163
T1   83.47±18.63   94.18±19.67 3.482 <0.001
T2   78.20±13.47   86.74±13.08 4.005 <0.001
T3 54.43±9.85   67.36±14.22 6.533 <0.001
T4 44.27±7.31 51.64±7.58 6.167 <0.001
T5 31.74±6.52 37.41±7.15 5.156 <0.001
T6 24.58±4.28 28.47±5.74 4.757 <0.001
T7 23.69±3.51 26.51±4.28 4.471 <0.001

Comparison of postoperative complications between groups A and B [n (%)].

Groups n Pulmonary infection Lung leak Atelectasis Arrhythmia Incidence rate (%)
A 74 0 (0.00) 1 (1.35) 2 (2.70) 6 (8.11) 12.16
B 82 2 (2.44) 1 (1.22) 3 (3.66) 8 (9.76) 17.07
χ2 value – – – – – 0.746
P-value – – – – – 0.388

Comparison of quality of life between groups A and B before and after operation (mean ± SD).

Group A (n=74) Group B (n=82)
Status scores Before operation After operation t value P-value Before operation After operation t value P-value
Physical status   19.35±2.81 19.25±1.83 0.257 0.798   19.36±2.68 19.07±2.13 0.743 0.459
Functional status   21.03±2.37 20.62±2.13 1.107 0.270   20.71±2.16 19.85±2.38 1.513 0.132
Emotional status   19.82±2.47 19.32±1.94 1.369 0.173   19.44±2.02 18.86±1.92 1.833 0.069
Social status   18.36±4.28 17.33±3.25 1.649 0.101   18.49±4.17 17.52±2.86 1.737 0.084
Additional status   24.05±5.36 23.16±4.03 1.142 0.256   23.51±4.13 22.72±3.11 1.384 0.168
Overall status 102.15±7.35 98.31±5.23 3.662 <0.001a 101.36±8.52 95.13±5.68 5.509 <0.001a

P<0.001 indicates statistical significance.